NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 123 filers reported holding NOVAVAX INC in Q3 2013. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $5,017,000 | +43.9% | 846,000 | +1.2% | 0.59% | +31.2% |
| Q3 2014 | $3,487,000 | +52.1% | 836,000 | +68.5% | 0.45% | +20.1% |
| Q2 2014 | $2,292,000 | +574.1% | 496,000 | +561.3% | 0.37% | +385.7% |
| Q1 2014 | $340,000 | -73.2% | 75,000 | -81.3% | 0.08% | -88.9% |
| Q3 2013 | $1,270,000 | – | 401,892 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |